Find

Wonach suchen Sie?

Weltweit

EUROIMMUN weltweit

Diese Webseite bietet eine Übersicht über die Geschäftsaktivitäten und Produkte der EUROIMMUN AG weltweit. Nicht alle Produkte sind in allen Ländern oder Regionen registriert und zugelassen. Bitte wenden Sie sich an Ihren Ländervertreter für Produktverfügbarkeit und Informationen:

EUROIMMUN Niederlassungen

Wählen Sie Ihr Land:

Fachartikel

von EUROIMMUN

10/01/2024

Featured on SelectScience

The indirect immunofluorescence assay (IFA) is an essential method in autoantibody diagnostics. The all-in-one device – UNIQO 160 from EUROIMMUN – provides complete ...

10/01/2024

Featured on SelectScience

Artificial intelligence (AI) can significantly enhance the evaluation of fluorescence patterns in indirect immunofluorescence assay (IFA) analyses. The EUROPattern ...

09/27/2024

Featured in Clinical Laboratory International

Candida auris (C. auris) is a globally emerging multidrug-resistant fungal pathogen, which spreads easily in health-care facilities and causes high ...

09/06/2024

Featured in Clinical Laboratory International

A unique portfolio of neurobiomarker tests – The testing landscape for neurological diseases has expanded rapidly in recent years due to the ...

06/15/2024

Featured in Clinical Laboratory International

The apolipoprotein E (APOE) genotype influences the development of Alzheimer’s disease and has recently been found to be a risk factor for side effects ...

Wonach suchen Sie?

Europa

Nordamerika

Süd- & Zentralamerika

Asien

Mittlerer Osten & Afrika

Fachartikel

von EUROIMMUN

Complete IFA automation with AI-enhanced evaluation

AI-enhanced evaluation software for immunofluorescence microscopy

Candida auris An emerging drug-resistant pathogen of global concern

Together at the pulse of neurobiology

APOE genotype A risk factor for adverse effects from anti-amyloid therapy in Alzheimer’s disease